Improve Health for nutrition
Improve HealthThe WSJ's Fictitious "Case Against Vitamins"
Vitamin opponents' efforts to steer you away from supplements have taken a frightening new direction. Attacks on vitamins are escalating from allegations of merely "useless" to "extremely dangerous." This alarming message is central to "The Case Against Vitamins," in the Wall Street Journal, March 20, 2006. The subhead sets the tone: "Recent studies show that many vitamins not only don't help. They may actually cause harm."
Should you throw away your vitamins? No. In assembling its "case," to scare people away from vitamins, the WSJ said much that is not scientifically accepted and left much unsaid. It cites carefully selected and sometimes outdated studies without proper perspective; misses or omits studies that contradict the premise, and fails to give a fair analysis by respected vitamin experts, choosing instead, sources of lesser expertise, credibility and credentials. Whether the bias is careless or reflects a mindset friendly to extensive pharmaceutical advertising, is impossible to tell.
Here's how the Wall Street Journal got it completely wrong about vitamins E, A and C, on which they based the major part of their "case."
Vitamin E in Wonderland
You might suspect the fix is in when the first person quoted by the WSJ is cardiologist Edgar R. Miller, author of one of the most criticized and denounced studies ever done on vitamin E. Eminent vitamin E researchers called his analysis, claiming common doses of vitamin E boosted death rates 4% to 6%, a case study in the misuse of statistics with laughable conclusions. If it were true, this absurd conclusion means taking vitamin E is more deadly than smoking, points out Jeffrey Blumberg, chief of antioxidant research at Tufts University. Dr. Blumberg and other vitamin E luminaries were so appalled, they signed a full page ad that ran in the New York Times, the Washington Post and USA Today, denouncing Miller's assertions that vitamin E was unsafe.
Dr. Blumberg also teamed up with 12 other international authorities to refute that vitamin E is unsafe at doses under 1600 IU a day, in the April, 2005 issue of the prestigious American Journal of Clinical Nutrition.
Among those condeming Miller's conclusions are world-renowned antioxidant and vitamin E researchers, Lester Packer PhD, University of Southern California, and Maret Traber, PhD, Oregon State University and authority on vitamin E toxicity for the National Academy of Sciences.
Miller's study, in fact, was exposed as bogus soon after it came out, its credibility destroyed by a major NIH study that found NO serious adverse effects, let alone death, in 40,000 women who took 600 IU of vitamin E every other day for ten years! If vitamin E was harmful or deadly, it surely would have shown up in this largest, longest vitamin E test ever done. Such a massive clinical trial overwhelmingly trumps previous studies like Miller's, and is irrefutable testimony to the utter safety of vitamin E at common doses, says Dr. Traber.
More remarkable, contrary to Miller's false predictions of death from vitamin E, the NIH study revealed it as an astonishing lifesaver. "It's the most exciting findings about vitamin E in 10 years!" said Dr. Traber.
The truth is heart deaths dropped 24% in women who took vitamin E. And it gets better. In women 65 and over, prime targets of heart attacks, vitamin E slashed death rates an incredible 49%--nearly in half!, the NIH study showed. This means taking vitamin E might save over 200,000 women a year from heart disease deaths, figures Dr. Traber.
Imagine. If a drug did that, it would be heralded as a miracle cure; doctors would wildly prescribe it, and its stock would soar, says Traber. But without huge drug money behind it, vitamin E is unfairly trashed as dangerous by the press and blacklisted by doctors, all to the detriment of people who could benefit greatly from it.
The Vitamin A Tales:
After repeating the widely-published hazards of high doses of beta carotene for current smokers, the WSJ "Case Against Vitamins," takes on vitamin A as cause of hip fractures, citing a 2002 Harvard nurses' study, that "associated" high vitamin A from foods, multivitamins and supplements, with a 48% higher risk for hip fractures. It is naive to use this study to slam supplements, since the greatest vitamin A threat came from consuming too much liver, not supplements. Nor was vitamin A a fracture hazard to women on estrogen, suggesting more complex factors than vitamin A.
Nor is the Harvard indictment of vitamin A the last word on the issue. Much research contradicts it. A 2004 large-scale, 9.5-year study of 34,703 postmenopausal women by the University of Minnesota, cleared vitamin A, in both supplements and food, of promoting fractures. Specifically researchers made clear there was "no evidence" that women who took the highest doses of vitamin A supplements were most apt to break a hip. (Lim LS, Osteoporos Int, 2004 Jul;15(7):552-9)
Most important, better-designed studies overshadow and refute the 4-year-old Harvard study that the WSJ relied on to build its anti-vitamin A case, and even suggest the opposite: that higher vitamin A, surprisingly, may also be tied to fewer fractures.
The difference comes from the way the study is designed. More current sophisticated research compares an individual's actual blood level of vitamin A with his or her bone density and fracture history. The Harvard study simply asked women what foods they ate, then estimated their vitamin A intake based on food-nutrient tables, and compared this with the number of fractures in the women. Obviously, this is a crude and unreliable measure of vitamin A status, compared with actual blood tests.
In several studies using blood tests, the vitamin A threat disappears or is turned upside down. At least, three recent studies that sampled blood for vitamin A content, either find no bone-hazard from vitamin A--or a LOWER risk of fractures.
British researchers at the University of Sheffield, scrutinized the blood of some 1200 women over age 75, searching for evidence that vitamin A induced fractures. No such thing. Women with the highest blood levels of vitamin A were 15% LESS apt to suffer a fracture of any bone, including the hip, than those with the lowest blood vitamin A. Women taking multivitamins (including vitamin A) or vitamin-A-dense cod liver oil were even better off--24% less apt to break a bone. (Barker ME, J Bone Miner Res.2005 Jun;20 (6):913-20.
At New York's Columbia University, a similar 22-year long study of 2799 American women ages 50 to 74, found that fracture risk nearly doubled in women with both the lowest and highest blood concentrations of vitamin A, adding more confusion and controversy to the debate. (Opotowsky AR, Am J Med 2004 Aug 1;117(3): 169-74)
In a side note, a recent Italian study showed that women with osteoporosis had lower blood levels of vitamin A, as well as vitamin C and E, suggesting lower antioxidant defenses against free radical damage may be involved in bone destruction and accelerated aging. (Maggio D.,J clin Endocrinol Metab 2003 Apr;88(4):1523-7).
Bottom Line: The issue of vitamin A and bones is unsettled and highly debatable. The evidence is conflicting and confusing. The WSJ's black and white "Case Against Vitamins," gave no indication of this. It presented vitamin A as a bone-hazard, case closed, hyping a fear of vitamin A among readers, when that is not an accepted scientific finding by any stretch. The jury is still out, and it could go several ways.
Vitamin C as Villain? Amazing
"Like other vitamin studies, research into vitamin C has been disappointing," recites the WSJ's Case Against Vitamins" saying it might not prevent colds or fight cancer, as Nobel prize-winner Linus Pauling promised it would 30 years ago. To press the point further, the WSJ article resurrects studies, asserting vitamin C can promote cancer and even death.
On the contrary, a new Japanese study says taking 500 mg of vitamin C daily cut odds of getting three or more colds over 5 years by 66%.
But that's of small consequence compared with dazzling new research identifying vitamin C as a promising new cancer drug. Excitement over the anticancer properties of vitamin C is dramatically escalating, rather than diminishing, among top-drawer scientists. It's hard to fathom how the Wall Street Journal missed this fact, since a quick search turns up dozens of studies of vitamin C's remarkable abilities to stop cancer.
Far from encouraging cancer growth, as the Wall Street Journal's outdated information asserted, vitamin C selectively targets and kills cancer cells, leaving normal cells unharmed, says groundbreaking research by Mark Levine, MD at the National Institutes of Health. High doses of vitamin C rapidly killed 100% of human lymphoma cells, reports Levine, as well as 9 other cancer cells, including breast, ovarian, lung, kidney and colon.
Moreover, Levine notes that some doctors already give high- dose intravenous vitamin C to help stop cancer. The evidence for increased survival and safety is so impressive, even in advanced late-stage cancer, that Levine has called for a "re-evaluation of vitamin C as cancer therapy."
Levine explains that for years researchers missed Pauling's point and failed to understand precisely how vitamin C destroys cancer cells and why very high doses are needed. In original studies, Pauling administered 10,000 milligrams of vitamin C a day intravenously to terminal cancer patients for about 10 days, and then high oral doses of C afterward. Those on vitamin C improved and survived longer. When Mayo Clinic researchers set out to verify Pauling's findings, they gave high oral doses, not intravenous doses, and concluded it didn't work. However, it is impossible, Levine notes, to raise vitamin C blood levels to cancer-lethal doses orally. The vitamin C vanishes too quickly. Doses deadly to cancer cells can be achieved only intravenously by jacking up blood levels of vitamin C 25 times higher than oral doses do.
For example, doctors at the University of Kansas gave two women with stage 3 ovarian carcinoma 60,000 mg of vitamin C intravenously twice a week, as well as conventional chemotherapy. Their tumors vanished and they showed no signs of cancer 3 1/2 years later. The doctors are now conducting a randomized test of high vitamin C (and other antioxidants) along with chemotherapy in women newly diagnosed with ovarian cancer.
More amazing: Dr. Levine and NIH colleagues personally documented three cases of advanced cancer in which vitamin C shrank tumors, dramatically increasing survival.
A 49-year-old man diagnosed with terminal bladder cancer in 1996 declined chemotherapy in favor of high-dose vitamin C infusions. Nine years later he is alive and cancer-free.
A 66-year-old woman with an aggressive lymphoma and a "dismal prognosis" in 1995, also rejected chemotherapy, but had radiation, and intravenous high-dose vitamin C. She, too is alive 10 years later.
A 51-year-old woman with kidney cancer that had spread to her lungs, opted for alternative therapy, including high-dose intravenous vitamin C given twice weekly for 10 months. Two months later, scans showed the tumors were gone. Her cancer remained in remission for four years. A smoker, she died of lung cancer that did not respond to the same therapy.
The Wall Street Journal is correct in saying that many doctors oppose use of antioxidants, including vitamin C, during chemotherapy, fearing interference with treatment. But experts point out the idea is only "theoretical," and has no evidence to justify it. The WSJ assertion that antioxidants may "promote some cancer and interfere with treatments," is without scientific merit. The one study that tested the theory found no difference in outcome--and certainly no worsening from antioxidants.
The latest evidence from the top experts at the National Institutes of Health not only rebuts the fictitious danger of vitamins to cancer patients, but shows that antioxidants, notably vitamin C, have the power to shrink cancer, produce remissions and dramatically extend life of even advanced cancer patients. Although it is still unclear how effective lower doses of vitamin C may be in preventing or fighting cancer, it is implausible that they could be harmful, considering that massive doses are not and, in fact, are so beneficial.
Should we hold our collective breath for the WSJ to do a major story on the ascent of vitamin C as a potentially powerful, inexpensive and incredibly safe cancer "drug?" Imagine the impact of that on pharmaceutical profits.
About the Author
Jean Carper is one of the world's most trusted authorities on food and supplements. She is a pioneering nutrition journalist, best-selling author, columnist for USA Weekend Magazine (600 newspapers, 50 million readers), host of "Outspoken Nutrition" on Health Radio Network and reports for XM Radio.
Rio Peruvian Maca 500mg 180 capsules Rio Peruvian Maca 500mg 180 capsules [] - �24.99
Organic Peat Free Compost
Raw Organic Cacao Nibs / Beans
Mangosteen Juice | Noni Juice | Noni
Labels: Superfood Supplements